Tara deBoer, PhD (She/her)

Tara deBoer, PhD has a wealth of experience in the life sciences industry. Tara began their career in 2010 as a Graduate Student at UC Santa Cruz in Distinguished Professor Pradip Mascharak's lab, where they focused on the design of systems using synthetic chemistry, materials science, and engineering to bridge technological gaps in biology. In 2015, they began their role as a Postdoctoral Researcher at UC Berkeley in Prof. Niren Murthy's group, where they developed unique strategies to overcome technological limitations contributing to the rise of antimicrobial resistance and led undergraduate researchers interested in creating unique chemical tools to probe the activity of CRISPR-Cas9. In 2017, they founded BioAmp Diagnostics, Inc., a company dedicated to improving patient care and fighting the rise of antimicrobial resistant bacteria through innovation in diagnostic testing. Tara currently serves as the company's CEO. In 2020, they began roles as a Guest Lecturer for the Biology+Business Program at the University of California, Berkeley, Haas School of Business and a Mentor Participant for the CLSI FAST Program - Matrubials at CLSI California Life Sciences Institute.

Tara deBoer obtained their Bachelor of Science (B.S.) in Chemistry from California State University, Stanislaus in 2008. Tara then went on to pursue their Doctor of Philosophy (PhD) in Chemistry and Biochemistry at the University of California, Santa Cruz, which they completed in 2015. Afterward, they worked as a Postdoctoral Researcher in Bioengineering at the University of California, Berkeley until 2019. In addition to their educational background, Tara has obtained certifications from the Associate of Medical Diagnostics Manufactures for Office of In Vitro Diagnostics and Radiological Health Submissions Workshop Training Completion in 2018, from Berkeley Law & Technology Group, LLC for FORM+FUND Berkeley Law Entrepreneur Program in 2017, and from UC Berkeley College of Engineering for Collaborative Institutional Training Initiative (CITI Program): Human Research, Biomedical Research Investigator in 2018.